New once-daily pill may improve kidney transplant outcomes
Disease control
Recruiting now
This study compares a once-daily anti-rejection drug (Envarsus XR) to the standard twice-daily drug in 78 adults receiving a kidney transplant. The goal is to see if the once-daily option reduces hidden rejection and improves immune system markers. Participants will be followed f…
Phase: PHASE2, PHASE3 • Sponsor: Roberto Gedaly • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC